Overview
Join Our Effort To Develop Drugs That Target The Pathways Of Human Disease
Regulus Therapeutics Inc. is a biopharmaceutical company leading the discovery of innovative new medicines based on microRNAs. Regulus is advancing microRNA therapeutics in several areas including hepatitis C infection, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus was established in September of 2007 by Alnylam Pharmaceuticals (Nasdaq:ALNY) and Isis Pharmaceuticals (Nasdaq:ISIS) and benefits substantially from their RNA therapeutic drug expertise. In April 2008, Regulus formed an alliance with GlaxoSmithKline to explore microRNA therapeutics for immuno-inflammatory diseases.
Regulus is located in Carlsbad, California and has a seasoned executive team experienced in corporate management, business, science and drug discovery.
Regulus seeks highly motivated, innovative and passionate team members for the following positions:
- RESEARCH ASSOCIATE
The successful candidate will focus primarily on development and validation of disease models as part of efforts for target validation and lead optimization Read More... - Pharmacology Research Associate
The successful candidate will focus primarily on efforts for target validation and lead optimization Read More...
